{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T05:42:35Z","timestamp":1694497355423},"reference-count":4,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,2,6]],"date-time":"2007-02-06T00:00:00Z","timestamp":1170720000000},"content-version":"vor","delay-in-days":158,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Skinmed"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1111\/j.1540-9740.2006.05928.x","type":"journal-article","created":{"date-parts":[[2007,2,7]],"date-time":"2007-02-07T00:53:03Z","timestamp":1170809583000},"page":"241-241","source":"Crossref","is-referenced-by-count":0,"title":["Xolegel (ketoconazole, 2%)"],"prefix":"10.1111","volume":"5","author":[{"given":"Noah S.","family":"Scheinfeld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,2,6]]},"reference":[{"key":"e_1_2_3_2_2","unstructured":"Barrier Therapeutics receives FDA approval of Xolegel(TM) gel for the treatment of seborrheic dermatitis. Available at:http:www.marketwire.commwreleasehtmlb1?releaseid=148710. AccessedAugust 8 2006."},{"key":"e_1_2_3_3_2","unstructured":"Barrier Therapeutics announces FDA acceptance of its new drug application for Sebazole (TM) topical gel. Available at:http:biz.yahoo.comiw0512090103552.html. AccessedAugust 8 2006."},{"issue":"3","key":"e_1_2_3_4_2","first-page":"AB146","article-title":"An open\u2010label study to evaluate the systemic absorption of ketoconazole in subjects applying ketoconazole USP 2% topical gel for the treatment of seborrheic dermatitis [abstract]","volume":"54","author":"Velde V","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_3_5_2","doi-asserted-by":"publisher","DOI":"10.1159\/000247566"}],"container-title":["SKINmed: Dermatology for the Clinician"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-9740.2006.05928.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1540-9740.2006.05928.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T10:43:04Z","timestamp":1694428984000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1540-9740.2006.05928.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":4,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["10.1111\/j.1540-9740.2006.05928.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1540-9740.2006.05928.x","archive":["Portico"],"relation":{},"ISSN":["1540-9740","1751-7125"],"issn-type":[{"value":"1540-9740","type":"print"},{"value":"1751-7125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}